Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations-Reference-Cited by-同舟云学术

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations

Published:2004-11 Issue:11 Volume:91 Page:1911-1915
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Whittemore A S, ,Balise R R,Pharoah P D P,DiCioccio R A,Oakley-Girvan I,Ramus S J,Daly M,Usinowicz M B,Garlinghouse-Jones K,Ponder B A J,Buys S,Senie R,Andrulis I,John E,Hopper J L,Piver M S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6602239.pdf

Reference21 articles.

1. Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles D, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Eerola H, Nevanlinna H, Syrjakoski K, Kalliomeni O-P, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with mutations in BRCA1 and BRCA2 detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72: 1117–1130

2. Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I – The analysis of case–control studies. IARC Sci Publ, (32): 5–338

3. Del Tito Jr BJ, Poff III HE, Novotny MA, Cartledge DM, Walker II RI, Earl CD (1998) Automated fluorescent analysis procedure for enzymatic mutation detection. Clin Chem 44: 731–739

4. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BAJ, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada-Hedman M, Breast Cancer Linkage Consortium (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676–689

5. Gayther SA, Russell P, Harrington P, Antoniou A, Easton DF, Ponder BAJ (1999) The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am J Hum Genet 65: 1021–1029

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contraceptive strategies for reducing the risk of reproductive cancers;International Journal of Gynecology & Obstetrics;2024-05-09

2. Endometrioid Over Kanseri ile Berrak Hücreli Over Kanseri Olan Olguların Prognozlarının Karşılaştırılması;Journal of Biotechnology and Strategic Health Research;2024-04-30

3. Complexity of the Genetic Background of Oncogenesis in Ovarian Cancer—Genetic Instability and Clinical Implications;Cells;2024-02-15

4. Contraception as chemoprevention of ovarian cancer in BRCA1 and BRCA2 women;Hormones;2023-12-19

5. Missed opportunities in the real-world genetic testing in BRCA gene variant carriers with cancers meeting NCCN criteria;Gynecologic Oncology;2023-03